Literature DB >> 17237246

Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats.

Stephanie W Watts1, Catherine Rondelli, Keshari Thakali, Xiaopeng Li, Bruce Uhal, Mohammad H Pervaiz, Ralph E Watson, Gregory D Fink.   

Abstract

Arterial remodeling occurs in response to mechanical and neurohumoral stimuli. We hypothesized that veins, which are not exposed to higher pressures in hypertension, would demonstrate less active remodeling than arteries. We assessed remodeling with two standard measures of arterial remodeling: vessel morphometry and the expression/function of matrix metalloproteinases (MMPs). Thoracic aorta and vena cava from sham normotensive and DOCA-salt hypertensive rats (110 +/- 4 and 188 +/- 8 mmHg systolic blood pressure, respectively) were used. Wall thickness was increased in DOCA-salt vs. sham aorta (301 +/- 23 vs. 218 +/- 14 mum, P < 0.05), as was medial area, but neither measure was altered in the vena cava. The aorta and vena cava expressed the gelatinases MMP-2, MMP-9, transmembrane proteinase MT1-MMP, and tissue inhibitor of metalloproteinase-2 (TIMP-2). Immunohistochemically, MMP-2 localized to smooth muscle in the aorta and densely in endothelium/smooth muscle of the vena cava. Western and zymographic analyses verified that MMP-2 was active in all vessels and less active in the vena cava than aorta. In hypertension, MMP-2 expression and activity in the aorta were increased (59.1 +/- 3.7 and 74.5 +/- 6.1 units in sham and DOCA, respectively, P < 0.05); similar elevations were not observed in the vena cava. MMP-9 was weakly expressed in all vessels. MT1-MMP was expressed by the aorta and vena cava and elevated in the vena cava from DOCA-salt rats. TIMP-2 expression was significantly increased in the aorta of DOCA rats compared with sham but was barely detectable in the vena cava of sham or DOCA-salt hypertensive rats. These findings suggest that large veins may not undergo vascular remodeling in DOCA-salt hypertension.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237246     DOI: 10.1152/ajpheart.00900.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  19 in total

1.  Chronic hyperhomocysteinemia causes vascular remodelling by instigating vein phenotype in artery.

Authors:  Poulami Basu; Natia Qipshidze; Utpal Sen; Srikanth Givvimani; Charu Munjal; Paras K Mishra; Suresh C Tyagi
Journal:  Arch Physiol Biochem       Date:  2011-08-13       Impact factor: 4.076

Review 2.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

3.  Pancreatic source of protease activity in the spontaneously hypertensive rat and its reduction during temporary food restriction.

Authors:  Amy Hsueh Wen Chan; Geert W Schmid-Schönbein
Journal:  Microcirculation       Date:  2019-05-03       Impact factor: 2.628

4.  Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR.

Authors:  Raquel C Antonio; Carla S Ceron; Elen Rizzi; Eduardo B Coelho; Jose E Tanus-Santos; Raquel F Gerlach
Journal:  Mol Cell Biochem       Date:  2013-10-10       Impact factor: 3.396

5.  Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension.

Authors:  Diogo M O Marçal; Elen Rizzi; Alisson Martins-Oliveira; Carla S Ceron; Danielle A Guimaraes; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-10-31       Impact factor: 3.000

6.  A comparison of reactive oxygen species metabolism in the rat aorta and vena cava: focus on xanthine oxidase.

Authors:  Theodora Szasz; Janice M Thompson; Stephanie W Watts
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-25       Impact factor: 4.733

7.  Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function.

Authors:  Poulami Basu; Utpal Sen; Neetu Tyagi; Suresh C Tyagi
Journal:  Vasc Health Risk Manag       Date:  2010-04-15

8.  Protective Role for Tissue Inhibitor of Metalloproteinase-4, a Novel Peroxisome Proliferator-Activated Receptor-γ Target Gene, in Smooth Muscle in Deoxycorticosterone Acetate-Salt Hypertension.

Authors:  Pimonrat Ketsawatsomkron; Henry L Keen; Deborah R Davis; Ko-Ting Lu; Madeliene Stump; T Michael De Silva; Aline M Hilzendeger; Justin L Grobe; Frank M Faraci; Curt D Sigmund
Journal:  Hypertension       Date:  2015-11-23       Impact factor: 10.190

9.  Differential expression of pancreatitis-associated protein and thrombospondins in arterial versus venous tissues.

Authors:  Theodora Szasz; Susan Eddy; Joseph Paulauskis; Robert Burnett; Merete Ellekilde; Juan L Iovanna; Stephanie W Watts
Journal:  J Vasc Res       Date:  2009-06-30       Impact factor: 1.934

10.  Influence of periostin-positive cell-specific Klf5 deletion on aortic thickening in DOCA-salt hypertensive mice.

Authors:  Hirofumi Zempo; Jun-Ichi Suzuki; Masahito Ogawa; Ryo Watanabe; Katsuhito Fujiu; Ichiro Manabe; Simon J Conway; Yoshiaki Taniyama; Ryuichi Morishita; Yasunobu Hirata; Mitsuaki Isobe; Ryozo Nagai
Journal:  Hypertens Res       Date:  2016-06-23       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.